| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Jun 02, 2023 | Option Exercise | $2.90 | 122,531 | 355,336 | 178,036 | Jun 02, 2023, 07:13 PM | |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Jun 02, 2023 | Option Exercise | $3.10 | 78,162 | 242,302 | 87,973 | Jun 02, 2023, 07:03 PM | |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Apr 05, 2023 | Sale | $108.42 | 10,000 | 1,084,200 | 9,811 | Apr 07, 2023, 09:02 PM | |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Apr 05, 2023 | Option Exercise | $3.70 | 10,000 | 37,000 | 19,811 | Apr 07, 2023, 09:02 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Mar 15, 2023 | Option Exercise | $2.90 | 25,000 | 72,500 | 80,144 | Mar 17, 2023, 09:02 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Mar 15, 2023 | Sale | $116.14 | 25,000 | 2,903,500 | 55,144 | Mar 17, 2023, 09:02 PM | |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Mar 06, 2023 | Option Exercise | $3.70 | 10,000 | 37,000 | 19,811 | Mar 08, 2023, 09:33 PM | |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Mar 06, 2023 | Sale | $122.13 | 10,000 | 1,221,300 | 9,811 | Mar 08, 2023, 09:33 PM | |
| RXDX | Prometheus Biosciences, Inc. | Cedars Sinai Intellectual Property Co | 10% Owner | Mar 08, 2023 | Sale | $114.59 | 865,000 | 99,120,347 | 4,001,132 | Mar 08, 2023, 09:30 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Mar 01, 2023 | Option Exercise | $3.70 | 700 | 2,590 | 55,844 | Mar 03, 2023, 09:30 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Mar 01, 2023 | Sale | $125.26 | 700 | 87,682 | 55,144 | Mar 03, 2023, 09:30 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Mar 03, 2023 | Option Exercise | $3.70 | 10,620 | 39,294 | 65,764 | Mar 03, 2023, 09:30 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Mar 03, 2023 | Sale | $125.13 | 10,620 | 1,328,881 | 55,144 | Mar 03, 2023, 09:30 PM | |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Feb 15, 2023 | Option Exercise | $3.70 | 5,000 | 18,500 | 14,811 | Feb 17, 2023, 09:34 PM | |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Feb 15, 2023 | Sale | $119.38 | 5,000 | 596,900 | 9,811 | Feb 17, 2023, 09:34 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Feb 17, 2023 | Sale | $125.10 | 13,680 | 1,711,368 | 55,144 | Feb 17, 2023, 09:31 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Feb 15, 2023 | Option Exercise | $2.90 | 25,000 | 72,500 | 80,144 | Feb 17, 2023, 09:31 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Feb 15, 2023 | Sale | $119.42 | 25,000 | 2,985,500 | 55,144 | Feb 17, 2023, 09:31 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Feb 16, 2023 | Option Exercise | $3.70 | 25,000 | 92,500 | 80,144 | Feb 17, 2023, 09:31 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Feb 16, 2023 | Sale | $119.87 | 25,000 | 2,996,750 | 55,144 | Feb 17, 2023, 09:31 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Feb 17, 2023 | Option Exercise | $3.70 | 13,680 | 50,616 | 68,824 | Feb 17, 2023, 09:31 PM | |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Jan 17, 2023 | Option Exercise | $3.70 | 5,000 | 18,500 | 14,811 | Jan 19, 2023, 08:42 PM | |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | Jan 17, 2023 | Sale | $119.00 | 5,000 | 595,000 | 9,811 | Jan 19, 2023, 08:42 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Jan 17, 2023 | Option Exercise | $2.90 | 25,000 | 72,500 | 80,144 | Jan 19, 2023, 08:39 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Jan 17, 2023 | Sale | $118.99 | 25,000 | 2,974,750 | 55,144 | Jan 19, 2023, 08:39 PM | |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | Dec 01, 2021 | Option Exercise | $2.90 | 15,400 | 44,660 | 15,400 | Dec 03, 2021, 07:02 PM | |
| RXDX | Prometheus Biosciences, Inc. | Cormorant Global Healthcare Master Fund, LP | Former 10% Owner | Mar 16, 2021 | Buy | $19.00 | 375,000 | 7,125,000 | 2,223,022 | Mar 18, 2021, 04:43 PM | |
| RXDX | Prometheus Biosciences, Inc. | Differentiated Ventures Investments, LLC | Former 10% Owner | Mar 16, 2021 | Buy | $19.00 | 800,000 | 15,200,000 | 2,648,024 | Mar 17, 2021, 07:47 PM | |
| RXDX | Prometheus Biosciences, Inc. | Stenhouse Mark | Chief Operating Officer | Mar 16, 2021 | Buy | $19.00 | 14,000 | 266,000 | 14,000 | Mar 16, 2021, 09:49 PM | |
| RXDX | Prometheus Biosciences, Inc. | PAPA JOSEPH C | Director | Mar 16, 2021 | Buy | $19.00 | 15,000 | 285,000 | 15,000 | Mar 16, 2021, 09:48 PM | |
| RXDX | Prometheus Biosciences, Inc. | Adams Helen C. | Director | Mar 16, 2021 | Buy | $19.00 | 500 | 9,500 | 500 | Mar 16, 2021, 09:47 PM | |
| RXDX | Prometheus Biosciences, Inc. | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10% Owner | Mar 16, 2021 | Buy | $19.00 | 850,000 | 16,150,000 | 3,314,032 | Mar 16, 2021, 08:30 PM | |
| RXDX | Prometheus Biosciences, Inc. | WONG RODERICK | 10% Owner | Mar 16, 2021 | Buy | $19.00 | 800,000 | 15,200,000 | 800,000 | Mar 16, 2021, 07:57 PM |
Menu